Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast 0.5% cream versus vehicle for moderate atopic dermatitis
2012-003000-12Phase 2Completed
- Sponsor
- Takeda
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing Roflumilast cream with Vehicle control (2 arms). Primary endpoint: Change from baseline to Day 15 in modified local SCORAD. Started Aug 2012; status: completed.
02
Drugs
roflumilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2012-003000-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003000-12.